Global POC Cardiac Market Size, Trends & Growth Opportunity and By Product Type (Cardiac Markers Test (Combinational Test Kits, Myoglobin Test, Brain Natriuretic Peptide (BNP) Test, Creatine Kinase MB isoenzyme (CK-MB) Test, and Cardiac troponin Test) and Analyzers)
By End User (Hospitals, Research Laboratories, Ambulatory Surgical Centers, and Diagnostic Laboratories), By Region and Forecast till 2027.
Global POC Cardiac Market 

The Global POC Cardiac Market is expected to grow from US$ 1.4 Billion in 2021 to US$ 2.0 Billion by 2027; it is estimated to grow at a CAGR of 6.12% from 2022 to 2027.

Cardiac POC is called as Cardiac Point of care which used to diagnose patients. POC includes cholesterol and coagulation testing as well as brain Natriuretic peptide test and troponin. Cardiac Point of care help in detection of enzyme detection which is relapsed by during cardiac condition like lactate, and troponin.

Market Drivers

Change in healthcare regulatory standards across the world and practitioner approach towards POC diagnostics is the key driving factor which is expected to boost the global POC cardiac market growth. Furthermore, Rise in government investments on development of healthcare infrastructure in order to facilitate advanced facilities will have the positive impact on market growth. Moreover, increase in incidences of chronic diseases will fuel the market growth. In addition to that, continuous technological advancements by key players expected to propel market growth during this forecast period.

Market Restraints

However, over the course of the forecast period, a number of factors, including stringent government regulations regarding product approval, rising costs for point-of-care testing equipment, product recalls, and industry resistance to changing the status quo, will limit market growth and present new challenges for the development of the cardiac point-of-care cardiac market.

Impact of Covid-19

Globally, the COVID-19 epidemic had a negative impact on many industries. However, the COVID-19 pandemic raised global public knowledge of health issues, which benefited the point-of-care cardiac market's expansion. Due to the demand for quick diagnostic findings, point-of-care testing has evolved into a crucial diagnostic tool. Research and development activities in the field of point-of-care cardiac have been accelerated by the identification of novel coronavirus strains. The point-of-care cardiac market has been greatly impacted by the pandemic, and businesses are working to create fast and precise viral detection technologies. Manufacturers all over the world are scrambling to create next-generation point-of-care systems that are quicker, easier, and more dependable as a result of the COVID-19 pandemic outbreak, which has increased demand for portable and transportable devices.

Segmentation By Product Type: Global POC Cardiac Market is segmented on the basis of Product Type into Cardiac Markers Test and Analyzers. Further Cardiac Markers Test is divided into Combinational Test Kits, Myoglobin Test, Brain Natriuretic Peptide (BNP) Test, Creatine Kinase MB isoenzyme (CK-MB) Test, and Cardiac troponin Test. 

Segmentation By End-user: Global POC Cardiac Market is segmented on the basis of End-user into Hospitals, Research Laboratories, Ambulatory Surgical Centers, and Diagnostic Laboratories. 

Segmentation By Region: Global POC Cardiac Market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. In 2021, North America is anticipated to rule the global POC Heart market. The rapidly expanding North American regional market is largely due to the well-established healthcare infrastructure, extraordinarily generous reimbursement standards, and the presence of several important industry participants.

Market Key Players

Various key players are discussed in this report such as Abbott Laboratories, Medtronic Inc, Roche Diagnostics, Boston Scientific Corp., Alere Inc, Mylab Discovery Solutions and Others.

Industrial Development

• High sensitive cardiac troponin T (cTnT-hs) and N-terminal pro-brain natriuretic peptide test, two crucial cardiac biomarkers based on Elecsys technology, were revealed by Roche in April 2021 as having five new intended uses (NT-proBNP). These clinical biomarkers support accurate heart failure treatment and heart attack detection.

Market Taxonomy

By Product Type 
• Cardiac Markers Test
o Combinational Test Kits
o Myoglobin Test
o Brain Natriuretic Peptide (BNP) Test
o Creatine Kinase MB isoenzyme (CK-MB) Test
o Cardiac troponin Test
• Analyzers

By End User
• Hospitals
• Research Laboratories
• Ambulatory Surgical Centers
• Diagnostic Laboratories

By Region
• North America
• Latin America
• Europe
• Asia Pacific
• Middle East & Africa

Key Questions Addressed by the Report
• What are the Key Opportunities in POC Cardiac Market?
• What will be the growth rate from 2022 to 2027?
• Which segment/region will have highest growth?
• What are the factors that will impact/drive the Market?
• What is the competitive Landscape in the Industry?
• What is the role of key players in the value chain?

Global POC Cardiac Market TOC:
1 Introduction
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global POC Cardiac Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global POC Cardiac Market, By Product Type
5.1 Y-o-Y Growth Comparison, By Product Type 
5.2 Global POC Cardiac Market Share Analysis, By Product Type 
5.3 Global POC Cardiac Market Size and Forecast, By Product Type
5.3.1 Cardiac Markers Test
5.3.1.1Combinational Test Kits
5.3.1.2Myoglobin Test Kit
5.3.3Brain Natriuretic Peptide (BNP) Test
5.3.4Creatine Kinase MB isoenzyme (CK-MB) Test
5.3.5Cardiac Troponin Test
5.3.2 Analyzers
6 Global POC Cardiac Market, By End User
6.1 Y-o-Y Growth Comparison, By End User
6.2 Global POC Cardiac Market Share Analysis, By End User
6.3 Global POC Cardiac Market Size and Forecast, By End User
6.3.1 Hospitals
6.3.2 Research Laboratories
6.3.3 Ambulatory Surgical Centres
6.3.4 Diagnostic Laboratories
7 Global POC Cardiac Market, By Region
7.1 Global POC Cardiac Market Share Analysis, By Region
7.2 Global POC Cardiac Market Share Analysis, By Region
7.3 Global POC Cardiac Market Size and Forecast, By Region
8 North America POC Cardiac Market Analysis and Forecast (2022 – 2027)
8.1 Introduction
8.2 North America POC Cardiac Market Share Analysis, By Product Type
8.3 North America POC Cardiac Market Size and Forecast, By End User
8.4 North America POC Cardiac Market Size and Forecast, By Country
8.4.1 U.S
8.4.2 Canada
8.4.3 Mexico
9 Europe POC Cardiac Market Analysis and Forecast (2022 – 2027)
9.1 Introduction
9.2 Europe POC Cardiac Market Share Analysis, By Product Type 
9.3 Europe POC Cardiac Market Size and Forecast, By End User 
9.4 Europe POC Cardiac Market Size and Forecast, By Country
9.4.1 Germany
9.4.2 France
9.4.3 UK
9.4.4. Rest of Europe
10 Asia Pacific POC Cardiac Market Analysis and Forecast (2022 – 2027)
10.1 Introduction
10.2 Asia Pacific POC Cardiac Market Share Analysis, By Product Type 
10.3 Asia Pacific POC Cardiac Market Size and Forecast, By End User 
10.4 Asia Pacific POC Cardiac Market Size and Forecast, By Country
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4. Rest of Asia Pacific
11 Latin America POC Cardiac Market Analysis and Forecast (2022 – 2027)
11.1 Introduction
11.2 Latin America POC Cardiac Market Share Analysis, By Product Type 
11.3 Latin America POC Cardiac Market Size and Forecast, By End User 
11.4 Latin America POC Cardiac Market Size and Forecast, By Country
12Middle East POC Cardiac Market Analysis and Forecast (2022 – 2027)
12.1 Introduction
12.2 Middle East POC Cardiac Market Share Analysis, By Product Type 
12.3 Middle East POC Cardiac Market Size and Forecast, By End User 
12.4 Middle East POC Cardiac Market Size and Forecast, By Country
13Competitive Analysis
13.1 Competition Dashboard
13.2 Market share Analysis of Top Vendors
13.3 Key Development Strategies
14Company Profiles
15.1 Abbott Laboratories
15.1.1 Overview
15.1.2 Offerings
15.1.3 Key Financials
15.1.4 Business Segment & Geographic Overview
15.1.5 Key Market Developments
15.1.6 Key Strategies
15.2 Medtronic Inc
15.2.1 Overview
15.2.2 Offerings
15.2.3 Key Financials
15.2.4 Business Segment & Geographic Overview
15.2.5 Key Market Developments
15.2.6 Key Strategies
15.3 Roche Diagnostics
15.3.1 Overview
15.3.2 Offerings
15.3.3 Key Financials
15.3.4 Business Segment & Geographic Overview
15.3.5 Key Market Developments
15.3.6 Key Strategies
15.4 Boston Scientific Corp
15.4.1 Overview
15.4.2 Offerings
15.4.3 Key Financials
15.4.4 Business Segment & Geographic Overview
15.4.5 Key Market Developments
15.4.6 Key Strategies
15.5 Alere Inc 
15.5.1 Overview
15.5.2 Offerings
15.5.3 Key Financials
15.5.4 Business Segment & Geographic Overview
15.5.5 Key Market Developments
15.5.6 Key Strategies
15.6 Others
15.6.1 Overview
15.6.2 Offerings
15.6.3 Key Financials
15.6.4 Business Segment & Geographic Overview
15.6.5 Key Market Developments
15.6.6 Key Strategies